Changes of Serum Concentrations of Brain-Derived Neurotrophic Factor (BDNF) during Treatment with Venlafaxine and Mirtazapine: Role of Medication and Response to Treatment

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Pharmacopsychiatry

• Publication date

  2012-09-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0032-1321908PMID 22961097
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlations between brain-derived neurotrophic factor and clinical symptoms in medicated patients with major depression.

  2011cited by this paper
• Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression

  2011cited by this paper
• Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat.

  2010cited by this paper
• Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial.

  2010cited by this paper
• Role of Brain-Derived Neurotrophic Factor in the Aetiology of Depression

  2010cited by this paper
• Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatment

  2010cited by this paper
• Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus.

  2009cited by this paper
• Correlations and Discrepancies between Serum and Brain Tissue Levels of Neurotrophins after Electroconvulsive Treatment in Rats

  2009cited by this paper
• Effects of escitalopram on the regulation of brain‐derived neurotrophic factor and nerve growth factor protein levels in a rat model of chronic stress

  2009cited by this paper
• Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.

  2009cited by this paper
• Effects of fluoxetine and venlafaxine on serum brain derived neurotrophic factor levels in depressed patients.

  2009cited by this paper
• Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.

  2008cited by this paper
• Outcomes in major depressive disorder: The evolving concept of remission and its implications for treatment

  2008cited by this paper
• Serum Concentrations of Nerve Growth Factor and Brain-Derived Neurotrophic Factor in Depressed Patients before and after Antidepressant Treatment

  2008cited by this paper
• Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications.

  2008cited by this paper
• Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.

  2008cited by this paper
• Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments.

  2008cited by this paper
• Serum neurotrophins--a study on the time course and influencing factors in a large old age sample.

  2007cited by this paper
• Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data.

  2007cited by this paper
• Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress‐induced decrease in cell proliferation and BDNF expression in rat hippocampus

  2006cited by this paper
• Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment.

  2006cited by this paper
• A neurotrophic model for stress-related mood disorders.

  2006cited by this paper
• Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women.

  2006cited by this paper
• Partial Normalization of Serum Brain-Derived Neurotrophic Factor in Remitted Patients after a Major Depressive Episode

  2005cited by this paper
• Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity.

  2005cited by this paper
• Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats.

  2005cited by this paper
• Repeated treatment with mirtazapine induces brain-derived neurotrophic factor gene expression in rats

  2005cited by this paper
• Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients

  2005cited by this paper
• Depression: a case of neuronal life and death?

  2004cited by this paper
• Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients.

  2004cited by this paper
• Hippocampal Brain-Derived Neurotrophic Factor Expression Following Treatment with Reboxetine, Citalopram, and Physical Exercise

  2004cited by this paper
• The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels.

  2004cited by this paper
• A BDNF Coding Variant is Associated with the NEO Personality Inventory Domain Neuroticism, a Risk Factor for Depression

  2003cited by this paper
• P.1.066 The effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients

  2003cited by this paper
• Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain.

  2003cited by this paper
• Antidepressive Treatment with Amitriptyline and Paroxetine: Effects on Saliva Cortisol Concentrations

  2003cited by this paper
• Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain.

  2003cited by this paper
• Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression

  2002cited by this paper
• Decreased serum brain-derived neurotrophic factor levels in major depressed patients.

  2002cited by this paper
• Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus

  2000cited by this paper
• Venlafaxine treatment stimulates blood platelet activity.

  2000cited by this paper
• Exercise, Antidepressant Medications, and Enhanced Brain Derived Neurotrophic Factor Expression

  1999cited by this paper
• Transport of brain-derived neurotrophic factor across the blood-brain barrier.

  1998cited by this paper
• Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments

  1995cited by this paper

• Late-Onset Depression in an Aging World: A Multidimensional Perspective on Risks, Mechanisms, and Treatment.

  2026cites this paper
• Abnormal neuritic microstructures in the anterior limb of internal capsules in treatment-resistant depression - A cross-sectional NODDI study.

  2025cites this paper
• Regional brain morphology and current antidepressant use: findings from 32 international cohorts from the ENIGMA major depressive disorder working group

  2025cites this paper
• Serum Brain-derived Neurotrophic Factor Levels as a Biomarker of Treatment Response in Patients With Depression: Systematic Review and Meta-analysis

  2025cites this paper
• The relationship between BDNF and physical activity on depression.

  2024cites this paper
• Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.

  2024cites this paper
• Effects of antidepressant and antipsychotic medication on peripheral brain-derived neurotrophic factor concentration: Systematic review and meta-analysis.

  2024cites this paper
• The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood.

  2024cites this paper
• An exploratory approach to identify microRNAs as circulatory biomarker candidates for epilepsy-associated psychiatric comorbidities in an electrical post-status epilepticus model

  2023cites this paper
• Effects of lithium on serum Brain‐Derived Neurotrophic Factor in Alzheimer’s patients with agitation

  2023cites this paper
• The role of BDNF in major depressive disorder, related clinical features, and antidepressant treatment: insight from meta-analyses.

  2023cites this paper
• Brain‐derived neurotrophic factor ( BDNF) variants and promoter I methylation are associated with prolonged nocturnal awakenings in older adults

  2023cites this paper
• The Serum Brain-Derived Neurotrophic Factor Increases in Serotonin Reuptake Inhibitor Responders Patients with First-Episode, Drug-Naïve Major Depression

  2023cites this paper
• Brain-Derived Neurotrophic Factor (BDNF) as a biomarker of treatment response in patients with Treatment Resistant Depression (TRD): A systematic review & meta-analysis.

  2022cites this paper
• BDNF-related mutations in major depressive disorder: a systematic review.

  2022cites this paper
• BDNF and its Role in the Alcohol Abuse Initiated During Early Adolescence: Evidence from Preclinical and Clinical Studies

  2022cites this paper
• Is Serum BDNF Altered in Acute, Short- and Long-Term Recovered Restrictive Type Anorexia Nervosa?

  2021cites this paper
• Amine Precursors in Depressive Disorders and the Blood-Brain Barrier

  2021cites this paper
• Effects of Antidepressant Treatment on Neurotrophic Factors (BDNF and IGF-1) in Patients with Major Depressive Disorder (MDD)

  2021cites this paper
• Molecular Basis of Late-Life Depression

  2021cites this paper
• Brain-Derived Neurotrophic Factor in the Cerebrospinal Fluid Increases During Electroconvulsive Therapy in Patients With Depression

  2020cites this paper
• Pathways Connecting Late-Life Depression and Dementia

  2020cites this paper
• Mirtazapine and Depressions

  2020cites this paper
• Neuroprotective roles of neurotrophic growth factors in mood disorders

  2020cites this paper
• Mirtazapine increases glial cell line-derived neurotrophic factor production through lysophosphatidic acid 1 receptor-mediated extracellular signal-regulated kinase signaling in astrocytes.

  2019cites this paper
• Successful Blue Economy Examples With an Emphasis on International Perspectives

  2019cites this paper
• Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels.

  2019cites this paper
• Adverse Effects of Pharmacological Treatments of Major Depression in Older Adults

  2019cites this paper
• Effect of Sertraline, Dosulepin, and Venlafaxine on Non-BDNF Neurotrophins in Patients With Depression: A Cohort Study

  2019cites this paper
• A study of brain-derived neurotrophic factor in Sprague-Dawley rats trained on a learned helplessness procedure.

  2018cites this paper
• Imaging correlates of behavioral impairments: An experimental PET study in the rat pilocarpine epilepsy model.

  2018cites this paper
• Serum brain‐derived neurotrophic factor (BDNF) in sleep‐disordered patients: relation to sleep stage N3 and rapid eye movement (REM) sleep across diagnostic entities

  2018cites this paper
• Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression

  2017cites this paper
• Peripheral levels of BDNF and opiate-use disorder: literature review and update

  2017cites this paper
• Serum brain-derived neurotrophic factor and stability of depressive symptoms in coronary heart disease patients: A prospective study.

  2017cites this paper
• Association analysis between mitogen-activated protein/extracellular signal-regulated kinase (MEK) gene polymorphisms and depressive disorder in the Han Chinese population.

  2017cites this paper
• The Comparison of Effectiveness of Various Potential Predictors of Response to Treatment With SSRIs in Patients With Depressive Disorder

  2017cites this paper
• The Etiology of Premenstrual Dysphoric Disorder: 5 Interwoven Pieces: A Better Understanding of the Causes of PMDD Can Lead to Improved Diagnosis and Treatment

  2017cites this paper
• Effects of aerobic exercise on brain metabolism and grey matter volume in older adults: results of the randomised controlled SMART trial

  2017cites this paper
• Depression and Obesity

  2016cites this paper
• Effect of Mirtazapine Treatment on Serum Levels of Brain-Derived Neurotrophic Factor and Tumor Necrosis Factor-α in Patients of Major Depressive Disorder with Severe Depression

  2016cites this paper
• Role of Serum Brain Derived Neurotrophic Factor and Central N-Acetylaspartate for Clinical Response under Antidepressive Pharmacotherapy

  2016cites this paper
• Exploring the Association between Serum BDNF and Attempted Suicide

  2016cites this paper
• Role of calcium, glutamate and NMDA in major depression and therapeutic application.

  2016cites this paper
• A prospective, longitudinal study of platelet serotonin and plasma brain-derived neurotrophic factor concentrations in major depression: effects of vortioxetine treatment

  2016cites this paper
• Premenstrual Dysphoric Disorder: Epidemiology and Treatment

  2015cites this paper
• A role of Yueju in fast-onset antidepressant action on major depressive disorder and serum BDNF expression: a randomly double-blind, fluoxetine-adjunct, placebo-controlled, pilot clinical study

  2015cites this paper
• Antidepressant Treatment with Venlafaxine and Mirtazapine: no Effect on Serum Concentration of Vascular Endothelial Growth Factor (VEGF)

  2015cites this paper
• 7,8-Dihydroxyflavone reduces sleep during dark phase and suppresses orexin A but not orexin B in mice.

  2015cites this paper
• Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients

  2015cites this paper
• Improved Alertness Is Associated with Early Increase in Serum Brain-Derived Neurotrophic Factor and Antidepressant Treatment Outcome in Major Depression

  2015cites this paper
• Neurotrophic factors in depression in response to treatment.

  2015cites this paper
• BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.

  2015cites this paper
• Serum brain-derived neurotrophic factor and cognitive functioning in underweight, weight-recovered and partially weight-recovered females with anorexia nervosa.

  2014cites this paper
• BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.

  2014cites this paper
• O fator neurotrófico derivado do cérebro (BDNF) como biomarcador nos transtornos psiquiátricos maiores

  2014cites this paper
• An Examination of the Long-lasting Effects of Lipopolysaccharide-induced Sepsis on Cognitive and Affective Behaviour in Mice

  2014cites this paper
• Venlafaxine protects methylglyoxal-induced apoptosis in the cultured human brain microvascular endothelial cells.

  2014cites this paper
• High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression

  2014influential citation
• Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)

  2014cites this paper
• The role of neurotrophins in major depressive disorder

  2013cites this paper
• On the quest for a biomechanism of transsexualism: is there a role for BDNF?

  2013cites this paper
• Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies

  2013cites this paper
• Akt2 Deficiency is Associated with Anxiety and Depressive Behavior in Mice

  2013cites this paper
• Clinical Interventions in Aging Dovepress Effects of Fluoxetine on Brain-derived Neurotrophic Factor Serum Concentration and Cognition in Patients with Vascular Dementia

  year unknowncites this paper